These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24884470)

  • 1. A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.
    Halder N; Kelso JK; Milne GJ
    BMC Infect Dis; 2014 May; 14():266. PubMed ID: 24884470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.
    Kelso JK; Halder N; Milne GJ
    BMC Infect Dis; 2013 Feb; 13():81. PubMed ID: 23398722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.
    Milne GJ; Halder N; Kelso JK
    PLoS One; 2013; 8(4):e61504. PubMed ID: 23585906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories.
    Kelso JK; Halder N; Postma MJ; Milne GJ
    BMC Public Health; 2013 Mar; 13():211. PubMed ID: 23496898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
    Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J
    BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic analysis of pandemic influenza vaccination strategies in Singapore.
    Lee VJ; Tok MY; Chow VT; Phua KH; Ooi EE; Tambyah PA; Chen MI
    PLoS One; 2009 Sep; 4(9):e7108. PubMed ID: 19771173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions.
    Pasquini-Descomps H; Brender N; Maradan D
    Value Health; 2017 Jun; 20(6):819-827. PubMed ID: 28577700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.
    Khazeni N; Hutton DW; Garber AM; Owens DK
    Ann Intern Med; 2009 Dec; 151(12):840-53. PubMed ID: 20008760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines.
    Milne G; Kelso J; Kelly H
    J R Soc Interface; 2010 Apr; 7(45):573-86. PubMed ID: 19755499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study.
    Khazeni N; Hutton DW; Collins CI; Garber AM; Owens DK
    Ann Intern Med; 2014 May; 160(10):684-94. PubMed ID: 24842415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitigation strategies for pandemic influenza A: balancing conflicting policy objectives.
    Hollingsworth TD; Klinkenberg D; Heesterbeek H; Anderson RM
    PLoS Comput Biol; 2011 Feb; 7(2):e1001076. PubMed ID: 21347316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective.
    Carrasco LR; Lee VJ; Chen MI; Matchar DB; Thompson JP; Cook AR
    J R Soc Interface; 2011 Sep; 8(62):1307-13. PubMed ID: 21296791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?
    Greer AL
    BMC Public Health; 2013 Jul; 13():669. PubMed ID: 23866760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies.
    Newall AT; Wood JG; Oudin N; MacIntyre CR
    Emerg Infect Dis; 2010 Feb; 16(2):224-30. PubMed ID: 20113551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
    Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive strategies for containing developing outbreaks of pandemic influenza.
    Andradóttir S; Chiu W; Goldsman D; Lee ML; Tsui KL; Sander B; Fisman DN; Nizam A
    BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S1. PubMed ID: 21356128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions.
    Dorratoltaj N; Marathe A; Lewis BL; Swarup S; Eubank SG; Abbas KM
    PLoS Comput Biol; 2017 Jun; 13(6):e1005521. PubMed ID: 28570660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) during an annual influenza epidemic and influenza pandemic in China.
    Caldwell R; Roberts CS; An Z; Chen CI; Wang B
    BMC Infect Dis; 2015 Jul; 15():284. PubMed ID: 26206275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.